| DEFENCE THERAPEUTICS A |
| Kanada |
| Gesundheit |
| CA24463V1013 / A3CN14 |
| DTC (Frankfurt) |
| FRA:DTC, ETR:DTC, DTC:GR |
| - |
| https://defencetherapeuti.. |
|
Defence Therapeutics Inc. is a publicly traded Canadian biotechnology company specializing in precision intracellular drug delivery to enhance cancer treatments. Its proprietary Accum platform improves the efficacy and safety of biological and biosim..
>Volltext.. |
| 19.65 Mio. EUR |
| 19.99 Mio. EUR |
| - |
| -2.54 Mio. EUR |
| -2.69 Mio. EUR |
| -0.05 EUR |
| 0.92 Mio. EUR |
| 0.59 Mio. EUR |
| -3.07 Mio. EUR |
| 0.86 |
| - |
| 2.05% |
| - |
| - |
| - |
| - |
| DEFENCE THERAPEUTICS, DEFENCE THERAPEUTIC |
| 25.04.26 |
|